Results for serumtransaminaser translation from Danish to English

stigning i serumtransaminaser
increase in serum transaminases

forhøjede leverenzymer (serumtransaminaser)
increase liver enzymes (serum transaminases)

ikterus forhøjede serumtransaminaser galdesten
increased serum transaminases gallstones

ikke almindelig: stigning i serumtransaminaser
uncommon: increase in serum transaminases

undersøgelser stigning i serumtransaminaser ikke almindelig:
investigations increase in serum transaminases uncommon:

bivirkninger, der vedrører leveren: forhøjede serumtransaminaser.
effects on liver: raised serum transaminases.

aktiv leversygdom eller uforklarlige, vedvarende stigninger i serumtransaminaser
active liver disease or unexplained persistent elevations of serum transaminases

der kan forekomme forhøjelser af serumtransaminaser under behandling med esbriet.
elevations of serum transaminases can occur during treatment with esbriet.

stigninger i forekomsten af serumtransaminaser bør føre til nøje monitorering og undersøgelse.
the occurrence of elevations in serum transaminases should lead to close monitoring and investigation.

-aktiv leversygdom, herunder uforklarlig vedvarende forhøjelse af serumtransaminaser over 3
renal or hepatic impairment:a starting dose of 10 mg a day is recommended in patients with moderate or severe renal impairment or significant hepatic impairment.

asymptomatiske stigninger i serumtransaminaser, der i de fleste tilfælde var milde og forbigående, forekom meget almindeligt hos patienter, behandlet med betaferon under kliniske studier.
asymptomatic elevations of serum transaminases, in most cases mild and transient, occurred very commonly in patients treated with betaferon during clinical trials.

hvis der er tegn på forværring af leversygdom eller persisterende forhøjelser af serumtransaminaser til mere end 5 gange den øvre grænse for normalområdet, skal fordelen ved fortsat behandling med efavirenz vurderes i forhold til de ukendte risici ved signifikant levertoksicitet.
if there is evidence of worsening liver disease or persistent elevations of serum transaminases to greater than 5 times the upper limit of the normal range, the benefit of continued therapy with efavirenz needs to be weighed against the potential risks of significant liver toxicity.

sjældne: stigning i serumtransaminaser (alanin aminotransferase, aspartat aminotransferase, γ - glutamyl transpeptidase) (se pkt.
rare: myopathy, rhabdomyolysis (see section 4.4), myalgia, muscle cramps

produkt-med aktiv leversygdom eller uforklarlig vedvarende stigning i serumtransaminaserne svarende til
-with active liver disease or unexplained persistent elevations of serum transaminases exceeding